MedPath

甘肃兰药药业有限公司

Ownership
-
Established
2006-12-22
Employees
-
Market Cap
-
Website
www.gansulanyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

458

NMPA:458

Drug Approvals

Afatinib Dimaleate Tablets

Product Name
马来酸阿法替尼片
Approval Number
国药准字H20249613
Approval Date
Dec 1, 2024
NMPA

Afatinib Dimaleate Tablets

Product Name
马来酸阿法替尼片
Approval Number
国药准字H20249612
Approval Date
Dec 1, 2024
NMPA

Etoposide

Product Name
依托泊苷
Approval Number
国药准字H62020944
Approval Date
Nov 6, 2024
NMPA

当归红枣颗粒

Approval Number
国药准字Z62020980
Approval Date
Oct 30, 2020
NMPA

Piperazine Phosphate Tablets

Product Name
磷酸哌嗪片
Approval Number
国药准字H20073524
Approval Date
Oct 30, 2020
NMPA

Bifendate Tablets

Product Name
联苯双酯片
Approval Number
国药准字H20073547
Approval Date
Jul 23, 2020
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H20073478
Approval Date
Jul 23, 2020
NMPA

Sulfamidine Tablets

Product Name
磺胺脒片
Approval Number
国药准字H20073499
Approval Date
Jul 23, 2020
NMPA

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H20073467
Approval Date
Jul 23, 2020
NMPA

Calcium Lactate,Calcium Gluconate and Calcium Hydrogen Phosphate Chewable Tablets

Product Name
三合钙咀嚼片
Approval Number
国药准字H20073536
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 46
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.